Leadership Overview
Enovis has 10 executives leading key functions including strategy, finance, operations, and global business units.
Driven by a culture of continuous improvement, Enovis is dedicated to improving lives by creating clinically differentiated solutions that help restore motion and enhance patient outcomes, partnering with experts to advance smarter, personalized, and more effective care.
Driven by a culture of continuous improvement, Enovis is dedicated to improving lives by creating clinically differentiated solutions that help restore motion and enhance patient outcomes, partnering with experts to advance smarter, personalized, and more effective care.
Leadership Roles at Enovis
Damien McDonald - Chief Executive Officer
Damien McDonald, the Chief Executive Officer at Enovis, directs the company's overarching strategy and operational execution. McDonald guides Enovis in its mission to improve lives through clinically differentiated medical technology, focusing on restoring motion and enhancing patient outcomes. This leadership involves fostering partnerships with healthcare experts to advance smarter, personalized, and more effective patient care. Overseeing global operations, the Chief Executive Officer ensures alignment with the company's commitment to innovation and strategic growth. By driving the development and deployment of a broad portfolio of products, services, and integrated technologies, Damien McDonald directly impacts the company's market position and its ability to support surgeons and clinicians. Ultimately, McDonald secures Enovis's long-term vision for advancing patient health and well-being.
Hj Lee - Chief Financial Officer
Hj Lee, the Chief Financial Officer at Enovis, oversees all financial operations and strategic financial planning. Lee manages the company's fiscal health, ensuring robust financial controls and driving profitable growth across global markets. This role involves directing capital allocation, managing investor relations, and optimizing financial performance to support Enovis's mission of enhancing patient outcomes. By analyzing market trends and financial data, the Chief Financial Officer provides critical insights to guide strategic decision-making. Hj Lee is responsible for financial reporting, budgeting, and forecasting, ensuring compliance with all regulatory requirements. Through meticulous financial management, Lee supports the company's culture of continuous improvement and strategic expansion, directly contributing to the sustained success of Enovis's innovative medical technologies.
Judith MacGowan - Regional Chief Financial Officer (APAC)
Judith MacGowan, the Regional Chief Financial Officer (APAC) at Enovis, directs financial strategy and operations across the Asia-Pacific region. MacGowan ensures financial integrity and drives fiscal performance within this key growth market, supporting Enovis's global expansion initiatives. This leadership position involves managing regional budgets, overseeing financial reporting, and optimizing resource allocation to align with corporate objectives. By providing critical financial analysis and guidance, the Regional Chief Financial Officer (APAC) supports local leadership in achieving operational and strategic goals. Judith MacGowan is instrumental in navigating the unique financial landscapes of the APAC market, fostering strong relationships with regional stakeholders and ensuring compliance with local regulations. MacGowan's expertise directly contributes to Enovis's ability to deliver differentiated solutions and enhance patient outcomes throughout the region.
Chi Egwuekwe - Vice President, Finance & Chief Financial Officer, Prevention & Recovery
Chi Egwuekwe, the Vice President, Finance & Chief Financial Officer, Prevention & Recovery at Enovis, leads financial strategy and operations for the Prevention & Recovery business segment. Egwuekwe manages financial planning, analysis, and reporting, ensuring fiscal discipline and driving profitable growth within this specialized division. This critical role involves optimizing financial resources to support the development and delivery of clinically differentiated solutions that restore motion and enhance patient outcomes. By providing expert financial guidance, the Vice President, Finance & Chief Financial Officer, Prevention & Recovery supports strategic decision-making and operational efficiency. Chi Egwuekwe is responsible for financial oversight, budgeting, and forecasting, ensuring alignment with Enovis's broader corporate objectives and market expansion goals. Egwuekwe's financial acumen directly contributes to the segment's success and the company's overall mission.
Barbara Serkin - Executive Assistant To Chief Human Resources Officer, P & R Group President and Senior Vice President, Supply Chain and Operations
Barbara Serkin, the Executive Assistant To Chief Human Resources Officer, P & R Group President and Senior Vice President, Supply Chain and Operations at Enovis, provides critical administrative and operational support to key executive functions. Serkin manages complex schedules, coordinates high-level meetings, and facilitates communication across multiple departments, ensuring seamless workflow for senior leadership. This role is vital in supporting the strategic initiatives of the Chief Human Resources Officer, the P & R Group President, and the Senior Vice President of Supply Chain and Operations. By maintaining efficient administrative processes, Barbara Serkin enables these leaders to focus on driving innovation, optimizing supply chain logistics, and advancing human resources strategies. Serkin's dedication ensures the smooth execution of critical business operations, directly contributing to Enovis's mission of enhancing patient outcomes and fostering a culture of continuous improvement.
Ronald Bublick - President
Ronald Bublick, the President at Enovis, holds a significant leadership position driving key strategic initiatives and operational oversight. Bublick's responsibilities encompass guiding business unit performance and ensuring alignment with Enovis's core mission of enhancing patient outcomes through medical technology innovation. This executive role involves directing cross-functional teams to achieve ambitious growth targets and operational excellence. By fostering a culture of continuous improvement, the President supports the development and deployment of clinically differentiated solutions that restore motion. Ronald Bublick is instrumental in advancing Enovis's market presence and strengthening its partnerships with healthcare experts. Bublick's leadership directly contributes to the company's sustained success and its commitment to providing smarter, more personalized, and effective patient care.
Gary Justak - Global President and General Manager, Foot & Ankle
Gary Justak, the Global President and General Manager, Foot & Ankle at Enovis, directs the strategic vision and operational execution for the Foot & Ankle business segment worldwide. Justak leads the development and commercialization of innovative solutions designed to restore motion and improve patient outcomes in this specialized area. This executive role involves overseeing global market strategies, driving product innovation, and ensuring operational excellence across all regions. By fostering strong relationships with healthcare professionals and key opinion leaders, the Global President and General Manager, Foot & Ankle enhances Enovis's market leadership. Gary Justak is responsible for achieving significant growth and profitability targets, ensuring the segment's contribution to the company's overall mission. Justak's leadership directly impacts the advancement of patient care and the expansion of Enovis's differentiated product portfolio.
Matthew Jewett - President, Recovery Sciences
Matthew Jewett, the President, Recovery Sciences at Enovis, spearheads the strategic direction and operational management of the Recovery Sciences division. Jewett focuses on advancing clinically differentiated solutions that help patients restore motion and achieve better health outcomes. This leadership position involves driving innovation in product development, expanding market reach, and ensuring the highest standards of quality and efficacy. By collaborating with healthcare experts, the President, Recovery Sciences enhances the delivery of personalized and effective care. Matthew Jewett is responsible for the segment's financial performance, strategic partnerships, and overall contribution to Enovis's mission. Jewett's expertise directly supports the company's commitment to continuous improvement and its role in transforming patient recovery journeys.
Mark Rutkin - Distributor Principle-President
Mark Rutkin, the Distributor Principle-President at Enovis, leads a critical distribution channel, ensuring the effective delivery of Enovis's medical technology solutions to healthcare providers. Rutkin manages the operational and strategic aspects of distribution, focusing on expanding market access and enhancing customer relationships. This role is vital in connecting Enovis's innovative products with the surgeons and clinicians who rely on them to improve patient outcomes. By optimizing supply chain logistics and distribution networks, the Distributor Principle-President ensures timely and efficient product availability. Mark Rutkin plays a key part in supporting Enovis's mission to restore motion and enhance patient well-being through reliable access to advanced medical technologies. Rutkin's leadership directly contributes to the company's market penetration and its commitment to advancing patient care.
Oliver Engert - Chief Administrative Officer
Oliver Engert, the Chief Administrative Officer at Enovis, oversees a broad range of administrative functions essential to the company's operational efficiency and strategic execution. Engert directs key support services, ensuring that Enovis operates smoothly and effectively across all global locations. This leadership role involves managing corporate infrastructure, optimizing internal processes, and ensuring compliance with administrative regulations. By streamlining operations and enhancing organizational effectiveness, the Chief Administrative Officer supports the company's mission to improve lives through innovative medical technologies. Oliver Engert plays a pivotal part in fostering a productive work environment and facilitating the seamless integration of services that underpin Enovis's commitment to advancing patient care. Engert's oversight directly contributes to the company's ability to deliver superior solutions and achieve strategic growth objectives.
Explore Leadership Teams in Manufacturing
At United Imaging, we develop and produce advanced medical products, digital healthcare solutions, and intelligent solutions that cover the entire process of imaging diagnosis and treatment. Founded in 2011, our company has subsidiaries and R&D centers in the United States, and other parts of the world. Our U.S. R&D facility opened in 2013 in Houston and was further established as the U.S. headquarters in 2018 with our service team and commercial organization in place. With a cutting-edge digital portfolio and a mission of broader access to healthcare for all, we help drive industry progress and bold change.
Company Leadership KB
JX
XC
Lantheus is a healthcare technology company headquartered in Bedford, Massachusetts with additional offices in New Jersey, Canada, and Sweden. Founded in 1956, the company pioneers medical imaging technologies and provides innovative diagnostics, targeted therapeutics, and artificial intelligence solutions for healthcare. Lantheus specializes in developing software and health technologies that empower clinicians to effectively identify, treat, and monitor various diseases. The company maintains a diverse product portfolio focused on enhancing patient care through advanced medical imaging and diagnostic tools. As a publicly traded company since 2019, Lantheus continues to expand its global presence while maintaining its commitment to innovation in healthcare technology.
Company Leadership
ROMTech® is thrilled to present our patented and groundbreaking rehabilitation technology, designed to serve a variety of orthopedic indications. Our revolutionary technology is improving patient outcomes, cutting cost of care, and overhauling the way postoperative orthopedic care is delivered.
Company Leadership GE
PL
MR
As per the "buy and build" strategy, the next acquisition was Legacy Medical (July 2018), followed by Haemotec (Nov 2019) and LTE Medical Supplies (Feb 2019). In April 2019, the company started an Ophthalmology business (EyeCare) and have expanded the company's product range and agencies in the existing verticals. The second half of 2019 saw further acquisitions with Paragmed in November and Jumla Medical Supplies and Stratmed joining the group in December. The company is a scaled and diversified group of specialised medical service providers committed to bringing new, first-rate technologies to a wide spectrum of medical practitioners. The company provides the latest devices, software, processes and procedures that facilitate high care and quality treatment for all patients. The company's clients and partners continually receive extensive training and comprehensive technical support as the company strives towards better products, better services and more personalised customer experiences. Depiction of Vertice MedTech
Company Leadership HP
GS
EM
BM
Frequently Asked Questions Regarding Enovis Top Executives and Leadership Team
